Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response염증성 장 질환 및 COVID-19 중증도와 장내 미생물총의 연관성: 변경된 면역 반응의 가능한 결과Review Published on 2022-05-052022-09-11 Journal: Current microbiology [Category] COVID19(2023년), SARS, 치료제, [키워드] alteration Altered Antiviral antiviral immune response ARDS Bacteroidaceae bowel Brain Cell chemokine chemokines circulation clearance COVID-19 COVID-19 patient cytokine Cytokine storm Cytokines disease Disease progression dominant drastic Dysbiosis dysfunction Enterococcus event events excessive secretion Fecal sample fecal samples Gut gut microbiome gut microbiota gut-lung axis Health help homeostasis hospitalized patients hyper inflammation immune immune cells immune dysfunction immunological impair Inflammatory bowel disease invading pathogen invading pathogens involved kidney Lungs metabolite metabolites Microbiome microorganism microorganisms modulated mucosal organ Pathogens physiological poor prognosis Presence replaced respiratory tract respiratory viral infection response SARS-CoV-2 severity Signaling Staphylococcus stimulate Streptococcus the cytokine storm viral infection Viral RNA virus [DOI] 10.1007/s00284-022-02877-7 PMC 바로가기 [Article Type] Review
Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-CCOVID-19 유도 MIS-C와 비교하여 COVID-19 ARDS가 있는 어린이의 병태생리학적 경로 차이Article Published on 2022-05-022022-09-11 Journal: Nature Communications [Category] 바이오마커, 유전자 메커니즘, 임상, 치료법, [키워드] Activation affected Analysis ARDS BCR children children with COVID-19 clinical feature Clinical features clinical phenotypes Coagulation complement contribute COVID COVID-19 described determine differentially expressed dysregulation expressed groups healthy children implicated Inflammatory less mass mass spectrometry metabolism MIS-C pathway Pathways performed plasma protein Protein proteomic proteomics retinoid scavenging Spectrometry susceptible Symptoms syndrome with COVID-19 [DOI] 10.1038/s41467-022-29951-9 PMC 바로가기 [Article Type] Article
Incidence, clinical associations and outcomes of intrathoracic complications with and without ARDS in COVID-19 pneumoniaResearch article Published on 2022-05-012022-10-05 Journal: Clinical imaging [Category] COVID19(2023년), SARS, 임상, [키워드] adjusted odds ratio Admission age ARDS association Care chest imaging Complication complications Computed tomography COVID-19 COVID-19 patient COVID-19 patients CTComputed Tomography CXR determine history Hospital stay hypertension ICU admission ICUIntensive Care Unit incidence increased risk independent risk factor initial intensive care unit Intrathoracic intubation Length of stay less lobar collapse LOSlength of stay male median MERS-CoVMiddle East respiratory syndrome (MERS-CoV) Middle East respiratory syndrome (MERS-CoV) Mortality no difference outcome outcomes Patient pleural effusion Pneumomediastinum Pneumonia Pneumothorax positive Predictive predictor reduction in Result Retrospective cross-sectional study reverse-transcriptase polymerase chain reaction risk RT-PCRreverse-transcriptase polymerase chain reaction SARS-CoV-2 SARS-CoVsevere acute respiratory syndrome Severe acute respiratory syndrome severity survival tested [DOI] 10.1016/j.clinimag.2022.02.029 [Article Type] Research article
Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications급성 호흡 곤란 증후군(ARDS) 및 중증 COVID-19에 대한 테트라사이클린 용도 변경: 최근 간행물에 대한 비판적 논의Article Published on 2022-05-012022-09-11 Journal: Expert opinion on investigational drugs [Category] COVID19(2023년), SARS, 신약개발, [키워드] activities acute respiratory distress acute respiratory distress syndrome addition antibiotic antiviral activity approach ARDS Area benefit Combination COVID-19 COVID-19 pandemic COVID-19 patients Critical doxycycline Drug repurposing Effectiveness Efficacy Evidence expert fibrosis immunomodulatory incyclinide inflammatory reaction initial limitation limitations Minocycline overcome pharmacological repurposing respiratory distress Respiratory distress syndrome safety profile SARS-CoV2 scarcity scientific evidence severe COVID-19 shown syndrome Tetracycline tetracyclines therapeutic potential therapy [DOI] 10.1080/13543784.2022.2054325 PMC 바로가기 [Article Type] Article
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical VentilationObservational Study Published on 2022-05-012022-10-04 Journal: Journal of cardiothoracic and vascular anesthesia [Category] COVID19(2023년), SARS, 임상, [키워드] activities activity acute phase acute respiratory distress acute respiratory distress syndrome Admission age ARDS Care change Chest computed tomography chest CT scan cognitive coronavirus disease Coronavirus disease 2019 COVID-19 daily living develop discharge discharged Dyspnea Follow-up functional had no hospital hospital discharge ICU improvement IMV intensive care intensive care unit Interaction Invasive mechanical ventilation investigated long-term survival lung Lung recovery majority measurement Mechanical offered Patient patients patients who survived patients with COVID-19 post-intensive care syndrome Prospective Psychological outcome pulmonary fibrosis Quality of life questionnaire receiving reported survival survived survivor syndrome undergo university hospital were assessed with COVID-19 [DOI] 10.1053/j.jvca.2021.11.032 PMC 바로가기 [Article Type] Observational Study
Programmed multi-level ventilation in COVID-19-related acute respiratory distress syndrome: a multi-center retrospective observational studyObservational Study Published on 2022-05-012022-10-04 Journal: The Journal of international medical research [Category] 임상, [키워드] acute respiratory distress acute respiratory distress syndrome Admission adverse events analyzed appear approach ARDS conducted coronavirus disease Coronavirus disease 2019 distress effective evaluated expiratory fraction Hypoxemia Intensive intensive care interquartile range mechanical ventilation mechanically ventilated patient median multicenter non-survivor outcome oxygen oxygen saturation Oxygenation Patient patients patients treated positive programmed multi-level ventilation Respiratory failure retrospective Retrospective study Safe stability survivor syndrome ventilated patient Ventilation ventilatory was used [DOI] 10.1177/03000605221101970 PMC 바로가기 [Article Type] Observational Study
The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: A retrospective cohort studyResearch article Published on 2022-05-012022-10-05 Journal: Annals of Medicine and Surgery [Category] 바이오마커, [키워드] affected Analysis ARDS Asymptomatic being biochemical marker biochemical markers Case fatality rate Clinical course clinical marker Clinical outcome COVID-19 COVID-19 positive patient cumulative death diabete diagnosed with COVID-19 disease course disease severity Dyspnea expected expired Fever Gastrointestinal hypertension ICU include individual Infection intensive care patient interstitial Kaplan-Meier survival analysis median age Mortality non-survivor occurred outcomes pandemic patchy Patient PCR polymerase chain Predictive predominant Probability radiological finding recovered patient reduced Result retrospective cohort study SARS-CoV-2 second wave severity severity and prognosis surpassed survival survivor Symptom the patient transmissions variant ventilator X-ray [DOI] 10.1016/j.amsu.2022.103599 [Article Type] Research article
[Inflammation during COVID-19]Article Published on 2022-05-012023-07-09 Journal: Revue médicale de Liège [Category] COVID19(2023년), [키워드] ARDS Cytokines Innate immunity Steroids thrombosis
Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patientsMeta-Analysis Published on 2022-05-012023-07-06 Journal: The Journal of asthma : official journal of the Association for the Care of [Category] COVID19(2023년), [키워드] ARDS Asthma COVID-19 ICU intubation SARS-CoV-2 [DOI] 10.1080/02770903.2021.1881970 [Article Type] Meta-Analysis
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDSSARS-CoV-2 유발 ARDS의 회복 단계에서 폐 확산 장애의 단백질체 프로파일링Article Published on 2022-05-012022-09-11 Journal: Clinical and Translational Medicine [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] ARDS diffusion impairment lung [DOI] 10.1002/ctm2.838 PMC 바로가기 [Article Type] Article